111 related articles for article (PubMed ID: 12591742)
21. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
Massa A; Barbieri F; Aiello C; Arena S; Pattarozzi A; Pirani P; Corsaro A; Iuliano R; Fusco A; Zona G; Spaziante R; Florio T; Schettini G
J Biol Chem; 2004 Jul; 279(28):29004-12. PubMed ID: 15123617
[TBL] [Abstract][Full Text] [Related]
22. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
23. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
[TBL] [Abstract][Full Text] [Related]
24. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
25. Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism.
Feldman AL; Stetler-Stevenson WG; Costouros NG; Knezevic V; Baibakov G; Alexander HR; Lorang D; Hewitt SM; Seo DW; Miller MS; O'Connor S; Libutti SK
Cancer Res; 2004 Jul; 64(13):4481-6. PubMed ID: 15231657
[TBL] [Abstract][Full Text] [Related]
26. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase.
Zhang L; Martelli ML; Battaglia C; Trapasso F; Tramontano D; Viglietto G; Porcellini A; Santoro M; Fusco A
Exp Cell Res; 1997 Aug; 235(1):62-70. PubMed ID: 9281353
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
[TBL] [Abstract][Full Text] [Related]
28. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
Campbell I; Magliocco A; Moyana T; Zheng C; Xiang J
Cancer Gene Ther; 2000 Sep; 7(9):1270-8. PubMed ID: 11023200
[TBL] [Abstract][Full Text] [Related]
30. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.
Furukawa T; Sunamura M; Motoi F; Matsuno S; Horii A
Am J Pathol; 2003 Jun; 162(6):1807-15. PubMed ID: 12759238
[TBL] [Abstract][Full Text] [Related]
31. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth.
Demers GW; Harris MP; Wen SF; Engler H; Nielsen LL; Maneval DC
Cancer Gene Ther; 1998; 5(4):207-14. PubMed ID: 9694072
[TBL] [Abstract][Full Text] [Related]
32. Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.
Ardini E; Agresti R; Tagliabue E; Greco M; Aiello P; Yang LT; Ménard S; Sap J
Oncogene; 2000 Oct; 19(43):4979-87. PubMed ID: 11042685
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer.
Kim J; Luo W; Chen DT; Earley K; Tunstead J; Yu-Lee LY; Lin SH
Cancer Res; 2003 Jan; 63(2):386-93. PubMed ID: 12543792
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
35. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.
Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460
[TBL] [Abstract][Full Text] [Related]
36. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin.
Reed CC; Gauldie J; Iozzo RV
Oncogene; 2002 May; 21(23):3688-95. PubMed ID: 12032837
[TBL] [Abstract][Full Text] [Related]
38. Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.
Libertini S; Iacuzzo I; Perruolo G; Scala S; Ieranò C; Franco R; Hallden G; Portella G
Clin Cancer Res; 2008 Oct; 14(20):6505-14. PubMed ID: 18927290
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12.
Zhang R; DeGroot LJ
Endocrinology; 2003 Apr; 144(4):1393-8. PubMed ID: 12639922
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.
Frizelle SP; Rubins JB; Zhou JX; Curiel DT; Kratzke RA
Cancer Gene Ther; 2000 Nov; 7(11):1421-5. PubMed ID: 11129284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
